For UK MedTech companies
Your medtech pipeline stalls every time NHS procurement resets
Capital sign-off routinely involves five or more stakeholders and an annual budget cycle that starts from zero. Clinician buy-in alone does not close deals, and each reset costs months of pipeline progress.
Two minutes. Solva follows up with specific procurement navigation options.
- Sales teams spending excessive time on administrative tasks rather than selling
- Innovative MedTech solutions failing to reach patients due to procurement bottlenecks
- Budget cycles resetting before deals are closed, forcing re-engagement
- High churn rates among sales personnel frustrated by slow progress.
- Inefficient resource allocation within sales and market access teams
- Delayed adoption of beneficial technologies by private healthcare providers
- Loss of potential revenue for MedTech companies due to extended sales cycles
- Increased operational costs for private healthcare providers due to reliance on older, less efficient technologies
- Delayed patient access to advanced diagnostic and treatment technologies
- Suboptimal patient outcomes due to the unavailability of cutting-edge medical devices
- Damage to MedTech companies' reputation as innovators if products are slow to market
- Negative perception of private healthcare providers as being slow to adopt new technologies
MedTech companies employing strategic sales and procurement navigation approaches can significantly shorten sales cycles, with some strategies aiming for a 20-30% reduction (Healthcare.digital, 2025).
Frequently asked questions
Why does this problem persist?
Capital procurement in UK healthcare is genuinely slow. The companies that navigate it successfully are the ones who understand the process, build relationships with procurement teams, and structure their commercial model to reduce the budget barrier.
What is the cost of leaving it unaddressed?
Fragmented NHS procurement deters investment and delays patient access to innovation, impacting the UK MedTech ecosystem (UK-CPI, 2025).
This is exactly what I do with UK private practices. Answer the few questions above and I'll come back personally with where to start. Paul.